Two Sigma Advisers’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-151,618
Closed -$277K 2529
2024
Q3
$277K Buy
151,618
+71,100
+88% +$146K ﹤0.01% 1940
2024
Q2
$167K Buy
80,518
+53,500
+198% +$156K ﹤0.01% 2248
2024
Q1
$108K Hold
27,018
﹤0.01% 2300
2023
Q4
$50.7K Sell
27,018
-800
-3% -$1.18K ﹤0.01% 2396
2023
Q3
$46.5K Sell
27,818
-3,500
-11% -$8.02K ﹤0.01% 2281
2023
Q2
$74.8K Sell
31,318
-300
-0.9% -$891 ﹤0.01% 2239
2023
Q1
$99K Sell
31,618
-15,600
-33% -$51.6K ﹤0.01% 2386
2022
Q4
$127K Sell
47,218
-5,200
-10% -$16.4K ﹤0.01% 2267
2022
Q3
$155K Sell
52,418
-700
-1% -$2.37K ﹤0.01% 2251
2022
Q2
$156K Sell
53,118
-12,800
-19% -$46.8K ﹤0.01% 2323
2022
Q1
$337K Sell
65,918
-105,000
-61% -$552K ﹤0.01% 2171
2021
Q4
$1.15M Buy
170,918
+2,100
+1% +$14.5K ﹤0.01% 1487
2021
Q3
$1.17M Buy
168,818
+110,500
+189% +$861K ﹤0.01% 1544
2021
Q2
$568K Buy
58,318
+46,200
+381% +$523K ﹤0.01% 1892
2021
Q1
$191K Sell
12,118
-7,400
-38% -$137K ﹤0.01% 2360
2020
Q4
$473K Buy
+19,518
New +$421K ﹤0.01% 1883

Other funds holding TARA

Two Sigma Advisers's TARA Position: Q4 2024 in Review

Two Sigma Advisers sold out of Protara Therapeutics (TARA) in Q4 2024, closing a stake of 151,618 shares — an estimated $277K sold.

Two Sigma Advisers first reported a position in TARA in Q4 2020 and held it in 16 quarters. The position peaked at $1.17M in Q3 2021. 60 funds tracked by Wall St. Rank hold TARA as of Q4 2024.

  • Two Sigma Advisers reported no remaining Protara Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 151,618 Protara Therapeutics shares in Q4 2024, an estimated $277K.
  • Two Sigma Advisers first reported a position in Protara Therapeutics in Q4 2020 and held it in 16 quarters.
  • Two Sigma Advisers's Protara Therapeutics position peaked at $1.17M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.